{
  "main_header": {
    "sid": 1002771,
    "name": "ERIS Lifescience",
    "stock_name": "ERIS Lifescience",
    "full_name": "ERIS Lifesciences Ltd",
    "name_url": "stocks-analysis/eris-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,406.70",
    "chg": 14.15,
    "chgp": "1.02%",
    "dir": 1,
    "prev_price": "1,392.55",
    "mcapval": "19,494.51 Cr",
    "mcap": "Small Cap",
    "scripcode": 540596,
    "symbol": "ERIS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE406M01024",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "17.72 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/eris-lifescience-1002771-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eris Lifesciences gains after Q1 PAT climbs 21% YoY to rs 142 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-29 14:50:19",
        "description": "Eris Lifesciences gains after Q1 PAT climbs 21% YoY to rs 142 cr  Business Standard..."
      },
      {
        "title": "ERIS Lifesciences consolidated net profit rises 20.68% in the June 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-29 14:45:10",
        "description": "ERIS Lifesciences consolidated net profit rises 20.68% in the June 2026 quarter  Business Standard..."
      }
    ],
    "total": 2,
    "sid": "1002771",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/eris-lifesciences-1002771"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Availing Working Capital Term Loan From Axis Bank",
      "datetime": "06-Aug-2026",
      "details": "as attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "04-Aug-2026",
      "details": "As Attached",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "29-Jul-2026",
      "details": "as attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ERIS Lifesciences Ltd has declared <strong>721%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Eris Lifesciences gains after Q1 PAT climbs 21% YoY to rs 142 cr

2026-07-29 14:50:19

Eris Lifesciences gains after Q1 PAT climbs 21% YoY to rs 142 cr Business Standard...

Read More

ERIS Lifesciences consolidated net profit rises 20.68% in the June 2026 quarter

2026-07-29 14:45:10

ERIS Lifesciences consolidated net profit rises 20.68% in the June 2026 quarter Business Standard...

Read More

View All News